Physician profile
Michael Magdy Bottros
NPI 1467661272
$182,064.21
in general payments reported to CMS, 2019-2025
14 companies · $109K in 2025
The $109K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $144 · 2021: $383 · 2022: $1,909 · 2023: $1,446 · 2024: $69K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $73K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Consulting Fee: $19K · Travel and Lodging: $16K · Food and Beverage: $8,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $72,565.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,555.00 |
| Consulting Fee | $18,562.50 |
| Travel and Lodging | $15,972.80 |
| Food and Beverage | $8,530.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $90,578.06 | 2023-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $56,745.17 | 2025 | |
| Avanos Medical | $22,140.78 | 2020-2025 | Cooled Rfa, Coolief* Cooled Radiofrequency, Generator |
| Boston Scientific Corporation | $9,361.79 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Vertos Medical, INC. | $1,190.16 | 2019-2022 | |
| Spr Therapeutics, INC | $576.80 | 2021-2025 | Sprint Pns System |
| Abbott Laboratories | $402.01 | 2019-2024 | Proclaim |
| Grt US Holding, INC. | $283.89 | 2022-2025 | Qutenza |
| Stryker Corporation | $252.29 | 2021-2025 | Mild Device Kit |
| Saluda Medical Americas, INC. | $226.89 | 2025 | Evoke |
| Nalu Medical, INC. | $188.56 | 2023-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $58.94 | 2019 | |
| Medtronic, INC. | $40.18 | 2024 | Intellis Adaptivestim |
| Baudax Bio INC. | $18.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bottros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.